Millennium Management’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.3K | Sell |
23,029
-171,391
| -88% | -$352K | ﹤0.01% | 5463 |
|
|
2025
Q4 | $546K | Buy |
194,420
+158,519
| +442% | +$368K | ﹤0.01% | 4884 |
|
|
2025
Q3 | $74K | Sell |
35,901
-1,090,769
| -97% | -$3.01M | ﹤0.01% | 5766 |
|
|
2025
Q2 | $3.55M | Buy |
1,126,670
+462,190
| +70% | +$1.41M | ﹤0.01% | 3334 |
|
|
2025
Q1 | $2.09M | Buy |
664,480
+223,536
| +51% | +$884K | ﹤0.01% | 3743 |
|
|
2024
Q4 | $1.91M | Buy |
440,944
+288,259
| +189% | +$901K | ﹤0.01% | 3685 |
|
|
2024
Q3 | $408K | Sell |
152,685
-86,924
| -36% | -$205K | ﹤0.01% | 4990 |
|
|
2024
Q2 | $532K | Sell |
239,609
-443,690
| -65% | -$1.67M | ﹤0.01% | 4544 |
|
|
2024
Q1 | $3.65M | Buy |
+683,299
| New | +$1.82M | ﹤0.01% | 3196 |
|
|
2023
Q3 | – | Sell |
-48,739
| Closed | -$71.6K | – | 6186 |
|
|
2023
Q2 | $71.6K | Sell |
48,739
-55,203
| -53% | -$89K | ﹤0.01% | 5400 |
|
|
2023
Q1 | $172K | Sell |
103,942
-36,825
| -26% | -$63.2K | ﹤0.01% | 5231 |
|
|
2022
Q4 | $197K | Sell |
140,767
-59,020
| -30% | -$84.5K | ﹤0.01% | 5343 |
|
|
2022
Q3 | $308K | Sell |
199,787
-193,816
| -49% | -$466K | ﹤0.01% | 5332 |
|
|
2022
Q2 | $866K | Buy |
393,603
+108,609
| +38% | +$182K | ﹤0.01% | 4506 |
|
|
2022
Q1 | $707K | Sell |
284,994
-133,886
| -32% | -$474K | ﹤0.01% | 4851 |
|
|
2021
Q4 | $2.52M | Buy |
418,880
+291,382
| +229% | +$1.74M | ﹤0.01% | 3553 |
|
|
2021
Q3 | $849K | Buy |
+127,498
| New | +$801K | ﹤0.01% | 4859 |
|
|
2021
Q2 | – | Sell |
-322,962
| Closed | -$2.99M | – | 6594 |
|
|
2021
Q1 | $2.99M | Buy |
322,962
+290,921
| +908% | +$3.53M | ﹤0.01% | 3139 |
|
|
2020
Q4 | $576K | Sell |
32,041
-61,912
| -66% | -$1.09M | ﹤0.01% | 4091 |
|
|
2020
Q3 | $1.33K | Buy |
+93,953
| New | +$620K | ﹤0.01% | 2923 |
|
|
2018
Q1 | – | Sell |
-1,547
| Closed | -$34K | – | 3696 |
|
|
2017
Q4 | $34K | Sell |
1,547
-3,208
| -67% | -$142K | ﹤0.01% | 3735 |
|
|
2017
Q3 | $250K | Sell |
4,755
-494
| -9% | -$30.8K | ﹤0.01% | 3136 |
|
|
2017
Q2 | $476K | Buy |
5,249
+3,420
| +187% | +$220K | ﹤0.01% | 2824 |
|
|
2017
Q1 | $151K | Sell |
1,829
-2,335
| -56% | -$317K | ﹤0.01% | 3277 |
|
|
2016
Q4 | $630K | Buy |
4,164
+3,834
| +1,162% | +$895K | ﹤0.01% | 2545 |
|
|
2016
Q3 | $107K | Buy |
+330
| New | +$120K | ﹤0.01% | 3117 |
|
|
2016
Q2 | – | Sell |
-183
| Closed | -$61K | – | 3223 |
|
|
2016
Q1 | $61K | Buy |
+183
| New | +$62.3K | ﹤0.01% | 3139 |
|
|
2015
Q4 | – | Sell |
-693
| Closed | -$284K | – | 3454 |
|
|
2015
Q3 | $284K | Buy |
+693
| New | +$363K | ﹤0.01% | 2939 |
|
|
2013
Q4 | – | Sell |
-273
| Closed | -$141K | – | 3491 |
|
|
2013
Q3 | $141K | Buy |
+273
| New | +$155K | ﹤0.01% | 3158 |
|
Other funds holding CRDF
VCM
LCM
P
ACA
FLPIM
Millennium Management's CRDF Position: Q1 2026 in Review
Millennium Management reduced its Cardiff Oncology (CRDF) stake by 88% in Q1 2026, selling an estimated $352K and leaving 23,029 shares worth $37.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5463.
Millennium Management first reported a position in CRDF in Q3 2013 and has held it in 29 quarters since. The position peaked at $3.65M in Q1 2024. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.
- Millennium Management held 23,029 shares of Cardiff Oncology worth $37.3K as of Q1 2026.
- Millennium Management sold 171,391 Cardiff Oncology shares in Q1 2026, an estimated $352K.
- Cardiff Oncology made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5463 holding.
- Millennium Management first reported a position in Cardiff Oncology in Q3 2013 and has held it in 29 quarters since.
- Millennium Management's Cardiff Oncology position peaked at $3.65M in Q1 2024.
- 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.